Melanóma: vizsgálatok itt: Izrael
13 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Beersheba, Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - 2. fázisTaking peopleA Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
- Where
- Afula, Jerusalem, Petah Tikva, Ramat Gan
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06961006 - 3. fázisTaking peopleStudy to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Where
- Jerusalem, Ramat Gan, Tel Aviv
- Életkor
- 18 év to 70 év
- People
- 670 worldwide
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT05727904 · EU 2022-503140-41-00 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Haifa, Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 1/2. fázisTaking peopleA Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Where
- Hod HaSharon
- Életkor
- 6 hónap to 17 év
- People
- 370 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00 - No phaseTaking peopleThe Multicentre Selective Lymphadenectomy Trial - 3
- Where
- Ramat Gan
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- Melanoma Institute Australia
See details and how to joinNCT07049276 - 3. fázisTaking peopleNeoadjuvant Darovasertib in Primary Uveal Melanoma
- Where
- Jerusalem, Ramat Gan
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07015190 · EU 2025-522387-32-00 - 1/2. fázisTaking peopleAutologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
- Where
- Jerusalem
- Életkor
- 18 év and over
- People
- 50
- Run by
- Hadassah Medical Organization
See details and how to joinNCT00722228 - 1/2. fázisTaking peopleModified Vaccine for High Risk or Low Residual Melanoma Patients
- Where
- Jerusalem
- People
- 50
- Run by
- Hadassah Medical Organization
See details and how to joinNCT01898039 - 1/2. fázisTaking peopleAnti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
- Where
- Jerusalem
- Életkor
- 18 év to 70 év
- People
- 3
- Run by
- Hadassah Medical Organization
See details and how to joinNCT05296564 - 2. fázisTaking peopleCrizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
- Where
- Ramat Gan
- Életkor
- 18 év and over
- People
- 33
- Run by
- Sheba Medical Center
See details and how to joinNCT05909618 - 1/2. fázisNot yet taking people in IzraelSingle-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.
- Where
- Petah Tikva
- Életkor
- 18 év to 100 év
- People
- 60
- Run by
- Rabin Medical Center
See details and how to joinNCT06896552 - No phaseTaking peopleAssessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma
- Where
- Jerusalem
- People
- 250
- Run by
- Hadassah Medical Organization
See details and how to joinNCT01438658